GO:0051724 NAD transmembrane transporter activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051724 (NAD transmembrane transporter activity) enables the transfer of NAD, in oxidized (NAD+) or reduced (NADH) form, across a biological membrane.
• The term covers both plasma-membrane and mitochondrial NAD transport, including the mitochondrial NAD+ carrier SLC25A51 and the yeast ortholog Ndt1p.
• NAD transmembrane transport controls compartmentalized NAD+ pools that feed redox reactions, sirtuins, PARPs and CD38-dependent signaling.
• Charged residues in the C- and M-gates of the yeast mitochondrial NAD+ transporter Ndt1p govern substrate recognition and transport activity.
• Dysregulated NAD+ transport is linked to acute myeloid leukemia, cardiac and neurological disease, and inflammatory signaling.
• CRISPR knockout, point-mutation, knock-in and overexpression models allow causal testing of NAD transporter genes in these disease contexts.
Description
NAD transmembrane transporter activity (GO:0051724) is a molecular function that enables the transfer of nicotinamide adenine dinucleotide (NAD) from one side of a membrane to the other. Because NAD+ and NADH cannot freely diffuse across lipid bilayers, dedicated transporter proteins are required to move these pyridine nucleotides between cellular compartments, thereby maintaining the distinct NAD+ pools that support mitochondrial oxidative metabolism, cytosolic glycolysis, and nuclear signaling. The term encompasses transport of both oxidized NAD (NAD+) and reduced NAD (NADH), as reflected by its synonyms NAD+ transporter activity and NADH transporter activity. Interest in GO:0051724 has grown with the identification of mitochondrial NAD+ carriers such as SLC25A51 in mammals and Ndt1p in yeast, which import NAD+ into the mitochondrial matrix and are essential for mitochondrial function and cell viability. Beyond mitochondria, NAD+ is released from cells and hydrolyzed by ectoenzymes such as CD38, generating signaling metabolites that act on ion channels and other targets. This makes NAD transmembrane transport a central node connecting bioenergetics, calcium signaling, and redox regulation. For researchers, GO:0051724 provides a precise annotation for genes and proteins whose primary biochemical activity is NAD translocation rather than NAD synthesis or consumption. Accurate annotation of this function is critical for interpreting genetic screens, metabolic flux experiments, and disease models in which compartmentalized NAD+ availability is perturbed.
NAD transmembrane transporter activity At A Glance
| GO ID | GO:0051724 |
|---|---|
| GO term | NAD transmembrane transporter activity |
| Ontology | molecular_function |
| Definition | Enables the transfer of NAD from one side of a membrane to the other. |
| Synonym | NAD+ transporter activity; NADH transporter activity; nicotinamide adenine dinucleotide transmembrane transporter activity; oxidized NAD transporter activity; reduced NAD transporter activity |
| Major function | Translocation of NAD+/NADH across mitochondrial or plasma membranes to maintain compartmentalized pyridine nucleotide pools |
| Representative proteins | SLC25A51 (mammalian mitochondrial NAD+ carrier) and Ndt1p (yeast mitochondrial NAD+ transporter) |
| Related processes | Mitochondrial NAD+ import, cellular NAD+ release, CD38-mediated NAD+ hydrolysis and calcium signaling |
| Disease relevance | Acute myeloid leukemia, cardiac and neurological disorders, inflammatory signaling |
What Is GO:0051724?
In simple terms, GO:0051724 describes the activity of a protein that carries NAD across a membrane. According to the QuickGO definition, this molecular function enables the transfer of NAD from one side of a membrane to the other. It includes transport of oxidized NAD (NAD+) and reduced NAD (NADH), and is therefore also known as NAD+ transporter activity, NADH transporter activity, or nicotinamide adenine dinucleotide transmembrane transporter activity. The function is distinct from NAD biosynthesis and from NAD-dependent enzyme activities such as sirtuins, PARPs, and CD38, although it directly influences them by controlling NAD availability in specific compartments.
Why Is NAD transmembrane transporter activity Important in Cell Biology?
NAD transmembrane transporter activity is important because it determines where NAD+ and NADH are available inside cells, and compartment-specific NAD+ pools control mitochondrial respiration, sirtuin activity, PARP-dependent DNA repair, and CD38-mediated calcium signaling. Without transporters annotated to GO:0051724, cells cannot import NAD+ into mitochondria or release it for extracellular signaling, and disruption of these transporters alters redox balance and cell survival. Consequently, this activity is a focal point for understanding metabolic disease, cancer, and neurodegeneration, and for designing experiments that manipulate NAD+ distribution rather than total NAD+ levels.
• Maintains mitochondrial NAD+ pools required for oxidative phosphorylation and cell viability.
• Supports cytosolic and nuclear NAD+ signaling that regulates sirtuins and PARPs.
• Enables extracellular NAD+ release and CD38-dependent calcium signaling.
• Controls redox homeostasis by balancing NAD+ and NADH across membranes.
• Is implicated in acute myeloid leukemia through SLC25A51-dependent mitochondrial NAD+ transport.
• Links NAD+ metabolism to cardiac and neurological disease via CD38 and NAD+ signaling.
• Modulates inflammatory responses through NAD+-dependent pathways such as SIRT1 and AMPK.
• Provides a druggable node for modulating compartmentalized NAD+ availability.
• Serves as a functional annotation target in genome-wide CRISPR screens of metabolic genes.
• Guides design of cell models with altered NAD+ transport for mechanistic studies.
NAD transmembrane transporter activity: Mechanism, Genes and Research Methods
Substrate recognition and binding
In simple terms: The transporter must first recognize and bind NAD before it can move it across the membrane.
NAD transmembrane transporters bind NAD+ or NADH with sufficient affinity and selectivity to distinguish them from other nucleotides. In the yeast mitochondrial NAD+ transporter Ndt1p, charged residues in the C- and M-gates contribute to substrate recognition and transport function, and mutation of these residues alters transport activity. Mammalian SLC25A51 similarly functions as a mitochondrial NAD+ carrier, and its activity is required to maintain mitochondrial NAD+ levels. These examples show that GO:0051724 activity depends on specific structural determinants that recognize the pyridine nucleotide substrate.
Conformational cycling and translocation
In simple terms: After binding NAD, the transporter changes shape to carry it across the membrane.
Transporters annotated to GO:0051724 are thought to undergo conformational changes that move bound NAD from one side of the membrane to the other. In Ndt1p, the C- and M-gates act as structural elements whose charged residues influence the transport cycle, consistent with a gated translocation mechanism. For SLC25A51, mitochondrial NAD+ import activity is essential for maintaining matrix NAD+ and supporting mitochondrial metabolism. These observations support a model in which substrate binding and conformational cycling are coupled to deliver NAD across the membrane.
Compartmentalization of NAD pools
In simple terms: Moving NAD across membranes creates separate NAD pools in different parts of the cell.
Because NAD+ cannot freely cross membranes, transporter activity annotated to GO:0051724 is required to establish and maintain distinct NAD+ pools in mitochondria, cytosol, and nucleus. Mitochondrial NAD+ import via SLC25A51 supports oxidative metabolism, while cytosolic and nuclear NAD+ supports signaling enzymes. Extracellular NAD+ released from cells can be hydrolyzed by CD38 to generate metabolites that regulate calcium signaling and other processes. Thus, NAD transmembrane transport is a key determinant of compartment-specific NAD+ availability.
Coupling to NAD-dependent signaling
In simple terms: The NAD that is transported can then be used by enzymes that depend on it.
NAD+ delivered by transporters feeds NAD-dependent enzymes including sirtuins, PARPs, and CD38. CD38 is a membrane-bound enzyme whose topology allows it to hydrolyze extracellular NAD+ and generate signaling molecules such as ADPR and cADPR, which regulate calcium signaling and ion channels. In macrophages, inhibition of extracellular calcium influx modulates IL-12 production through a CaMKKbeta-AMPK-SIRT1 pathway, illustrating how NAD+-dependent signaling intersects with inflammatory responses. These connections show that GO:0051724 activity is functionally coupled to diverse NAD-dependent processes.
Regulation of transporter activity
In simple terms: Cells can adjust how much NAD is moved across membranes depending on their needs.
The activity of NAD transporters can be regulated at the level of expression, localization, and intrinsic transport properties. Structural studies of Ndt1p indicate that charged residues in the C- and M-gates are important for function, providing a basis for regulation through sequence variation or post-translational modification. In disease contexts such as acute myeloid leukemia, SLC25A51-dependent mitochondrial NAD+ transport is proposed as a therapeutic target, implying that transporter activity is tuned to meet metabolic demands. Additionally, extracellular NAD+ availability for CD38-mediated signaling depends on release and transport processes that are responsive to cellular state.
Key Genes Involved in GO:0051724 NAD transmembrane transporter activity
The following genes and proteins are directly or functionally associated with NAD transmembrane transporter activity (GO:0051724) and its downstream NAD-dependent processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SLC25A51 | Mitochondrial NAD+ carrier that imports NAD+ into the matrix | Central to mitochondrial NAD+ transport studies and acute myeloid leukemia research |
| NDT1 | Yeast mitochondrial NAD+ transporter with C- and M-gates | Model for structure-function analysis of NAD+ transport |
| CD38 | Membrane-bound NAD+ hydrolase generating calcium signaling metabolites | Links NAD+ metabolism to cardiac, neurological and immune signaling |
| SIRT1 | NAD+-dependent deacetylase involved in inflammatory and metabolic regulation | Readout of NAD+ availability and signaling in macrophages |
| AMPK | Energy sensor modulated by CaMKKbeta and NAD+-dependent pathways | Connects NAD+ signaling to cellular energy homeostasis |
| PARP1 | NAD+-consuming enzyme in DNA repair | NAD+ transport affects PARP1 substrate availability |
| SLC25A52 | Mitochondrial carrier family member related to NAD+ transport | Potential modifier of mitochondrial NAD+ pools |
| SLC25A53 | Mitochondrial carrier family member | Candidate for comparative NAD+ transport studies |
| NNT | Mitochondrial transhydrogenase influencing NADPH/NAD+ balance | Indirectly affects mitochondrial NAD+ redox state |
| NAMPT | NAD+ biosynthesis enzyme | Provides substrate for compartmentalized NAD+ pools |
| NMNAT1 | Nuclear NAD+ synthesis enzyme | Nuclear NAD+ supply relevant to transport studies |
| NMNAT2 | Cytosolic NAD+ synthesis enzyme | Cytosolic NAD+ pool maintenance |
| NMNAT3 | Mitochondrial NAD+ synthesis enzyme | Complements mitochondrial NAD+ transport |
| CD157 | ADP-ribosyl cyclase family member | Paracrine regulation of NAD+-dependent processes |
| TRPM2 | Ion channel regulated by pyridine nucleotides | Readout of NAD+ metabolite signaling |
| RYR | Calcium release channel modulated by NAD+ metabolites | Links NAD+ transport to calcium signaling |
| SARM1 | NAD+ hydrolase in axon degeneration | Consumes NAD+ and affects compartmental NAD+ pools |
How Is NAD transmembrane transporter activity Regulated?
NAD transmembrane transporter activity is regulated at multiple levels. Expression and localization of transporters such as SLC25A51 and Ndt1p determine transport capacity, and charged residues in the C- and M-gates of Ndt1p are required for normal function, suggesting that structural features control transport efficiency. Cellular NAD+ demand from sirtuins, PARPs, and CD38 can influence transporter-dependent NAD+ distribution, and CD38-mediated NAD+ hydrolysis generates metabolites that regulate calcium signaling and ion channels. Inflammatory signaling through CaMKKbeta-AMPK-SIRT1 also intersects with NAD+ availability, providing a feedback link between cellular stress and NAD+ metabolism. Together, these mechanisms allow cells to adjust NAD+ transport according to metabolic and signaling needs.
NAD transmembrane transporter activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SLC25A51 | Acute myeloid leukemia; mitochondrial NAD+ transport | SLC25A51 knockout and overexpression in AML cell lines |
| CD38 | Cardiac and neurological disease; calcium signaling | CD38 knockout cells and NAD+ release assays |
| SIRT1 | Inflammatory signaling in macrophages | SIRT1 knockout macrophages with IL-12 readout |
| TRPM2 | Ion channel regulation by pyridine nucleotides | TRPM2 point-mutation and calcium imaging |
| NDT1 | Mitochondrial NAD+ transport model | Yeast Ndt1p point-mutation and transport assays |
Acute myeloid leukemia and mitochondrial NAD+ transport
SLC25A51-dependent mitochondrial NAD+ transport has been implicated in acute myeloid leukemia, where maintaining mitochondrial NAD+ pools supports leukemic cell metabolism and survival. Because GO:0051724 activity controls mitochondrial NAD+ import, targeting this function is proposed as a therapeutic strategy in AML, and experimental models that alter SLC25A51 activity can test whether transport is causally required for disease phenotypes.
Cardiac and neurological disease linked to CD38 and NAD+ signaling
CD38 connects the heart and brain through NAD+ metabolism and calcium signaling, and its activity depends on extracellular NAD+ availability that is influenced by NAD+ release and transport processes. Dysregulated CD38-mediated NAD+ hydrolysis has been associated with cardiac and neurological dysfunction, making NAD transmembrane transport and related pathways relevant to these conditions. Experimental systems that modulate NAD+ transport can help determine how compartmental NAD+ changes contribute to disease.
Inflammation and immune signaling
NAD+-dependent pathways modulate inflammatory responses. In LPS-treated murine macrophages, inhibition of extracellular calcium influx enhances IL-12 production by downregulating the CaMKKbeta-AMPK-SIRT1 signaling pathway, which depends on NAD+ availability. Because SIRT1 activity requires NAD+, changes in NAD+ transport that alter cytosolic or nuclear NAD+ pools could influence inflammatory signaling, providing a rationale for studying GO:0051724 in immune cell models.
Ion channel regulation and calcium signaling
Pyridine nucleotides and their metabolites regulate ion channels, including TRPM2 and ryanodine receptors, linking NAD+ metabolism to calcium signaling. CD38-generated metabolites such as ADPR and cADPR act on these channels, and extracellular NAD+ must be available for CD38 to produce them. Therefore, NAD transmembrane transport processes that supply extracellular NAD+ can indirectly shape calcium-dependent cellular responses relevant to cardiac and neuronal function.
From NAD transmembrane transporter activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SLC25A51 required for mitochondrial NAD+ import and cell survival? | SLC25A51 knockout cell line |
| Do charged residues in Ndt1p gates control NAD+ transport? | NDT1 point-mutation yeast strains |
| Can tagged SLC25A51 be used to monitor localization? | Knock-in of epitope tag at endogenous SLC25A51 locus |
| Does overexpression of a NAD+ transporter alter compartmental NAD+ pools? | Overexpression cell model with NAD+ biosensor |
| Does CD38-mediated NAD+ hydrolysis depend on extracellular NAD+ supply? | CD38 knockout and NAD+ release assays |
| Does SIRT1 mediate inflammatory responses to NAD+ changes? | SIRT1 knockout macrophages with IL-12 readout |
How to Study the NAD transmembrane transporter activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function phenotype | Test requirement for SLC25A51 or NDT1 |
| Point mutation | Specific residue function | Analyze Ndt1p C- and M-gates |
| Knock-in tagging | Protein localization and interactions | Tag endogenous SLC25A51 |
| Overexpression | Gain-of-function effects on NAD+ pools | Increase transporter levels and measure NAD+ |
| NAD+ biosensor imaging | Compartmental NAD+ levels | Monitor mitochondrial vs cytosolic NAD+ |
| Calcium imaging | Downstream calcium signaling | Assess CD38-NAD+ metabolite effects |
| RNA-seq | Transcriptional changes | Profile inflammatory or metabolic responses |
| Proteomics | Protein abundance and interactions | Identify NAD+ transport-associated complexes |
Genetic perturbation and phenotyping
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of genes annotated to GO:0051724. For example, SLC25A51 knockout can reveal requirements for mitochondrial NAD+ import and cell survival, while point mutations in Ndt1p gates can dissect structure-function relationships. These models can be combined with metabolic and viability assays to link transport activity to phenotype.
NAD+ measurement and biosensors
Quantifying NAD+ and NADH in specific compartments is essential for studying NAD transmembrane transporter activity. Genetically encoded NAD+ biosensors and biochemical assays can report changes in mitochondrial, cytosolic, or nuclear NAD+ pools following transporter perturbation. Such measurements help distinguish transport effects from changes in NAD+ synthesis or consumption.
Calcium and ion channel assays
Because NAD+ metabolites regulate ion channels and calcium signaling, calcium imaging and electrophysiology can be used to assess downstream consequences of NAD+ transport. CD38-generated metabolites such as ADPR and cADPR act on channels including TRPM2 and ryanodine receptors, providing functional readouts of NAD+ availability.
Transcriptomic and proteomic profiling
RNA-seq and proteomics can identify expression changes and interaction partners associated with NAD transporters. For example, inflammatory signaling through CaMKKbeta-AMPK-SIRT1 can be monitored by transcript and protein readouts in macrophages. Combining these methods with genetic perturbation of GO:0051724 genes helps define the broader network influenced by NAD+ transport.
How CRISPR Can Be Used to Study GO:0051724 NAD transmembrane transporter activity
Knockout
CRISPR knockout of genes such as SLC25A51 or NDT1 can abolish NAD transmembrane transporter activity and reveal its requirement for mitochondrial NAD+ import, cell survival, and downstream signaling. Knockout models are useful for testing whether a candidate gene is necessary for a phenotype linked to GO:0051724.
Point Mutation
Point mutations can be introduced into residues predicted to be important for NAD+ binding or gating, as shown for the C- and M-gates of Ndt1p. Such models allow precise structure-function analysis of NAD transmembrane transport without completely removing the protein.
Knock-in
Knock-in of tags or reporters at endogenous loci enables visualization and quantification of NAD transporter localization and dynamics. For example, tagging SLC25A51 can help determine where it acts within mitochondria and how its distribution changes under metabolic stress.
Overexpression
Overexpression of NAD transporters can increase compartmental NAD+ import and test sufficiency for phenotypes such as altered metabolism or signaling. Overexpression models complement knockout studies by showing whether increased transport activity is sufficient to drive a cellular response.
How EDITGENE Supports NAD transmembrane transporter activity Research
Researchers studying NAD transmembrane transporter activity-related genes often need to determine whether a candidate gene is causally involved in NAD+ compartmentalization, metabolic regulation, or disease phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise manipulation of genes such as SLC25A51, CD38, and NDT1, allowing functional interrogation of GO:0051724 in relevant cellular contexts.
Contact EDITGENE today to design your custom CRISPR model for NAD transmembrane transporter activity research.
Frequently Asked Questions About NAD transmembrane transporter activity
What is NAD transmembrane transporter activity?
NAD transmembrane transporter activity (GO:0051724) is a molecular function that enables the transfer of NAD, including NAD+ and NADH, from one side of a membrane to the other.
What genes are involved in NAD transmembrane transporter activity?
Key genes include SLC25A51 in mammals and NDT1 in yeast, which encode mitochondrial NAD+ carriers, as well as related NAD metabolism genes such as CD38, SIRT1, and NAMPT.
What is the GO ID for NAD transmembrane transporter activity?
The Gene Ontology ID is GO:0051724, under the molecular_function aspect.
Why is NAD+ transport important for mitochondria?
Mitochondria cannot synthesize all the NAD+ they need, so transporters such as SLC25A51 import NAD+ to support oxidative metabolism and cell survival.
How is NAD transmembrane transporter activity studied?
Researchers use CRISPR knockout, point mutations, knock-in tagging, overexpression, NAD+ biosensors, calcium imaging, RNA-seq, and proteomics to study this activity.
Is NAD transmembrane transporter activity linked to cancer?
Yes, SLC25A51-dependent mitochondrial NAD+ transport has been implicated in acute myeloid leukemia and is considered a potential therapeutic target.
What is the difference between NAD+ transporter and NADH transporter activity?
Both are covered by GO:0051724; the term includes transport of oxidized NAD (NAD+) and reduced NAD (NADH) across membranes.
How does CD38 relate to NAD transmembrane transport?
CD38 is a membrane-bound enzyme that hydrolyzes extracellular NAD+ to generate calcium signaling metabolites, so NAD+ release and transport influence its activity.
Can CRISPR be used to study NAD transporters?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models allow precise functional analysis of NAD transporter genes such as SLC25A51 and NDT1.
What diseases are associated with defects in NAD transport?
Dysregulated NAD+ transport has been linked to acute myeloid leukemia, cardiac and neurological disease, and inflammatory signaling.
Conclusion
NAD transmembrane transporter activity (GO:0051724) is a defined molecular function that moves NAD+ and NADH across membranes, shaping compartmentalized NAD+ pools that drive mitochondrial metabolism, sirtuin and PARP signaling, and CD38-dependent calcium signaling. Genes such as SLC25A51 and NDT1 provide tractable models for dissecting the structural and regulatory features of this transport activity. Because NAD+ compartmentalization is increasingly implicated in cancer, cardiac and neurological disease, and inflammation, precise CRISPR-based models are valuable for causal studies. EDITGENE supports this research with knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to NAD transporter biology.
References
- 1. Tao Y et al.. 2025. CD38 connects the heart and brain.. Transl Psychiatry 15(1):342 PMID: 40935818
- 2. Liu X et al.. 2016. Inhibition of Extracellular Calcium Influx Results in Enhanced IL-12 Production in LPS-Treated Murine Macrophages by Downregulation of the CaMKKβ-AMPK-SIRT1 Signaling Pathway.. Mediators Inflamm 2016:6152713 PMID: 27313401
- 3. Astigiano C et al.. 2022. Paracrine ADP Ribosyl Cyclase-Mediated Regulation of Biological Processes.. Cells 11(17) PMID: 36078044
- 4. Rong C et al.. 2026. SLC25A51 and mitochondrial NAD⁺ transport in acute myeloid leukemia: mechanisms, therapeutic potential, and translational perspectives.. Hum Cell 39(8) PMID: 42472419
- 5. Kilfoil PJ et al.. 2013. Regulation of ion channels by pyridine nucleotides.. Circ Res 112(4):721-41 PMID: 23410881
- 6. Wang T et al.. 2024. Nanoarchitectonics with a Membrane-Embedded Electron Shuttle Mimics the Bioenergy Anabolism of Mitochondria.. Angew Chem Int Ed Engl 63(10):e202319116 PMID: 38225920
- 7. Lee HC et al.. 2022. The calcium signaling enzyme CD38 - a paradigm for membrane topology defining distinct protein functions.. Cell Calcium 101:102514 PMID: 34896700
- 8. Miniero DV et al.. 2024. Functional Roles of the Charged Residues of the C- and M-Gates in the Yeast Mitochondrial NAD(+) Transporter Ndt1p.. Int J Mol Sci 25(24) PMID: 39769317
